Conversely, inflammation-low subtypes mainly included low mortality, methylated MGMT promoter status, IDH mutant status, 1p19q codeletion status, WHO II grade, and oligodendroglioma histology (Fig. 2C and D). Here, MGMT is linked to oligodendroglioma.